Skip to main content
. 2021 Apr;9(7):559. doi: 10.21037/atm-20-4583

Figure 3.

Figure 3

Spearman correlation analysis between metabolites and clinical features (A) and Receiver operator curve for the selected metabolite in PD-N versus PD-CI (B). *, P<0.05. AUC, area under the curve; PD-N, Parkinson’s disease without cognitive impairment; PD-CI, Parkinson’s disease with cognitive impairment.